Active TopicsActive Topics  Display List of Forum MembersMemberlist  CalendarCalendar  Search The ForumSearch  HelpHelp
  RegisterRegister  LoginLogin

Stock Synopsis
 The Equity Desk Forum :Investment Ideas - Creating winning portfolios! :Stock Synopsis
Message Icon Topic: Unichem Labs - Finding favour with funds Post Reply Post New Topic
Author Message
RAKESH
Groupie
Groupie


Joined: 17/Aug/2006
Online Status: Offline
Posts: 93
Quote RAKESH Replybullet Topic: Unichem Labs - Finding favour with funds
    Posted: 05/Sep/2006 at 5:22pm
sir i wnt to why u dont post message on any pharma company...
and want to know of unichem labs
IP IP Logged
basant
Admin Group
Admin Group
Avatar

Joined: 01/Jan/2006
Location: India
Online Status: Offline
Posts: 18403
Quote basant Replybullet Posted: 05/Sep/2006 at 5:53pm
We did discuss Vimta Labs - which is into contract research and the stock is also up from some Rs 158 to Ts 195 today.Boradly I do not understand pharma and technology and that is why I  do not write about them
 
Unichem (CMP Rs 239) does appear attractive at a trailing PE of 10.5 times.. The stock is in demand and is being accumulated by Templetoon, and investors could hold on or buy more also.
 
The company ahs shown consistent growth over the past 3 years and that too without diluting additional equity.The Return ratios are also very healthy.
 
Now on the down side the dividend yield at 4% looks great as any fall in price will make the yield more attractive and arrest the downside.
 
But as I keep repeating with pharma and technology it is very essential to have some idea about the business as an investor cannot go with financials alone.
 

CMP

Rs 239.15

Market cap

Rs 860.94

Sales Fy 06

453.15

EPS Fy 06

22.48

Dividend

10.00

PE

10.5 times

RoE

29.47%



Edited by basant - 05/Sep/2006 at 5:56pm
'The Thoughtful Investor: A Journey to Financial Freedom Through Stock Market Investing' - A Book on Equity Investing especially for Indian Investors. Book your copy now: www.thethoughtfulinvestor.in
IP IP Logged
manishdave
Senior Member
Senior Member


Joined: 05/Aug/2006
Location: India
Online Status: Offline
Posts: 1371
Quote manishdave Replybullet Posted: 16/Sep/2006 at 11:02pm
I am watching this company for long time. It has increased dividend very consistantly has given bonuses. Growth is very good after handsome dividends and without dilution. Price doent tell what this company diserves and I look this as an opportunity.
 
 
IP IP Logged
monu_duggad
Senior Member
Senior Member
Avatar

Joined: 07/Sep/2006
Location: India
Online Status: Offline
Posts: 289
Quote monu_duggad Replybullet Posted: 17/Sep/2006 at 8:01pm
Manish/Basantjee
 
Whats your take on Matrix labs ? I got in during the acquisition announcement by Milan.
If you think you can,You Can
IP IP Logged
sajanvm
Groupie
Groupie
Avatar

Joined: 18/Jul/2006
Location: India
Online Status: Offline
Posts: 91
Quote sajanvm Replybullet Posted: 17/Sep/2006 at 10:33pm
Both Unichem Labs & JB Chem are of similar size and are available at 10 PE. Indian Pharma market is extremely attractive and is growing at 15% (see the latest report on World Pharma market) in the HDFC Securities website.
I believe that both Uncihem & JB Chem are re-rating candidates. They trade at commodity valuations when for example JB derives over 90% of revenues from branded formulations. They both have excellent track records of performance & shareholder rewards over a long period of time.
It is interesting that New Vernon private equity subscribed to a preferential issue from both these companies last year - at prices that are about 20-25% higher than today's market price.
Sajan
IP IP Logged
excel_monkey
Senior Member
Senior Member
Avatar

Joined: 17/Nov/2009
Online Status: Offline
Posts: 1281
Quote excel_monkey Replybullet Posted: 29/Nov/2011 at 10:59pm
Any reason why this quality name has been beaten down?
Inventory adjustment cannot suffice as the only reason
I have a vested interest in the stocks I discuss, therefore I would request you to kindly consider my comments with a pinch of salt and do your own due diligence
IP IP Logged
rapidriser
Senior Member
Senior Member
Avatar

Joined: 18/Nov/2007
Location: India
Online Status: Offline
Posts: 966
Quote rapidriser Replybullet Posted: 29/Nov/2011 at 10:02am
Originally posted by excel_monkey

Any reason why this quality name has been beaten down?
Inventory adjustment cannot suffice as the only reason


Thanks EM for bringing this to my notice. Definitely looks interesting at these beaten down levels.


When all else is lost, the future still remains. - Christian Nestell Bovée
IP IP Logged
hit2710
Senior Member
Senior Member
Avatar

Joined: 15/Jun/2009
Location: India
Online Status: Offline
Posts: 4013
Quote hit2710 Replybullet Posted: 29/Nov/2011 at 10:18am
Originally posted by rapidriser

Thanks EM for bringing this to my notice. Definitely looks interesting at these beaten down levels.


Yes it does look interesting. Its cardiac brands are well established.

If one looks at the results for the last three quarters then there is sequential improvement. Compared to earlier year quarters the results do look poor but these were due to the restructuring taken up by the company.

Unichem is a company with negligible debt and gradually seems to be getting on track. Worth keeping a watch on.
Stockmarket is a weird place. For every person who buys a stock there is a person who sells it and both think they are very smart.
IP IP Logged
Post Reply Post New Topic
Printable version Printable version

Forum Jump
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot delete your posts in this forum
You cannot edit your posts in this forum
You cannot create polls in this forum
You cannot vote in polls in this forum



This page was generated in 0.109 seconds.
Bookmark this Page